Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Immunotherapy
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
namilumab
(IZN-101) / Amgen, Izana Biosci, Roivant
prezalumab
(AMG 557) / Amgen, AstraZeneca
PD 360324
/ Pfizer
dapirolizumab pegol
(CDP7657) / Biogen, UCB, Nektar Therap
AGS-009
/ CoImmune
IBC-VS01
/ Orban Biotech
MDX-1342
/ BMS
MEDI-570
/ AstraZeneca
MK-8808
(rituximab biosimilar) / Merck (MSD)
Turalio
(pexidartinib) / Daiichi Sankyo
Uplizna
(inebilizumab-cdon) / Mitsubishi Tanabe, Amgen
